---
title: "AstraZeneca shares slump after $400bn BMS merger rumours"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294714332.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-08-03T15:03:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294714332.md)
  - [en](https://longbridge.com/en/news/294714332.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294714332.md)
---

# AstraZeneca shares slump after $400bn BMS merger rumours

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)

## Related News & Research

- [Ascent Group LLC Has $3.21 Million Stake in Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/295994083.md)
- [17,077 Shares in Bristol Myers Squibb Company $BMY Purchased by Avaii Wealth Management LLC](https://longbridge.com/en/news/296315075.md)
- [AstraZeneca Reports Mixed Lung Cancer Trial Outcomes From Three Pivotal Studies](https://longbridge.com/en/news/296114723.md)
- [FDA grants accelerated approval to Bristol Myers Squibb’s ZENBEXUS for relapsed multiple myeloma combo use](https://longbridge.com/en/news/295848217.md)
- [North Dakota State Investment Board Boosts Holdings in Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/296020226.md)